Atri Pharma Research (India) Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 4.78 M
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 32.59%
- Ebitda -0.36%
- Net Worth -0.73%
- Total Assets -0.06%
About Atri Pharma Research (India)
Atri Pharma Research (India) Private Limited (APRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 February 2009 and has a history of 15 years and 11 months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 4.78 M, as per Ministry of Corporate Affairs (MCA) records.
Nixon Patel and Santosh Varalwar serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2009PTC062684
-
Company No.
062684
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Feb 2009
-
Date of AGM
25 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Atri Pharma Research (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Varalwar
|
Director | 02-Feb-2009 | Current |
|
Nixon Patel
|
Director | 02-Feb-2009 | Current |
Financial Performance of Atri Pharma Research (India).
Atri Pharma Research (India) Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.59% increase in profit. The company's net worth dipped by a decrease of 0.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atri Pharma Research (India)?
In 2020, Atri Pharma Research (India) had a promoter holding of 2.09% and a public holding of 97.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Uquifa India Private LimitedSantosh Varalwar is a mutual person
-
Qulabs Software (India) Private LimitedNixon Patel is a mutual person
-
Yantra Software Private LimitedNixon Patel is a mutual person
-
Vivimed Labs LimitedSantosh Varalwar is a mutual person
-
B B R Projects Private LimitedSantosh Varalwar is a mutual person
-
Kreative Hosts Atria Private Limited
Santosh Varalwar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Atri Pharma Research (India)?
Unlock and access historical data on people associated with Atri Pharma Research (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atri Pharma Research (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atri Pharma Research (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.